Search results
Results from the WOW.Com Content Network
A leading researcher in brain regulation of body weight, Cone also serves as vice provost and director of U-M's biosciences initiative. The managing director is Anna Schork. The institute's first director was Jack E. Dixon. In 2002, Mary Sue Coleman, U-M's president, appointed cell biologist and expert on insulin signaling Alan R. Saltiel as ...
The General Motors X platform (also called X-body) is a rear-wheel drive compact car automobile platform produced from the 1962 to 1979 model years. Developed by Chevrolet, the architecture was initially unique in the U.S. to the Chevy II, first joined by the Pontiac Ventura in 1971, then a range of other GM products as its divisions expanded their compact model lines.
Acta Biológica Colombiana; American Journal of Physical Anthropology; The American Naturalist; Annual Review of Physiology; Asian-Australasian Journal of Bioscience and Biotechnology
Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation, is a non-departmental public body (NDPB), and is the largest UK public funder of non-medical bioscience. It predominantly funds scientific research institutes and university research departments in the UK.
Used for creating a viable embryo from a body cell and an egg cell: Developmental biology: Southern blot: Used to detect specific DNA sequence in DNA samples: Molecular biology: Test cross: Used to determine whether an individual is homozygous or heterozygous dominant: Genetics: Voltage clamp
Verily Life Sciences LLC, [2] also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. [3] [4] The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc.
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small ...
He is a founder of several biotechnology companies, including Cambridge Biosciences, The Virus Research Institute, ProScript, LeukoSite, Dendreon, Diversa, X-VAX, and Demetrix. He was a founder chairman and CEO of Human Genome Sciences , a company that pioneered the application of genomics to drug discovery.